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Campylobacter  
jejuni HS:23  
and Guillain-Barré  
Syndrome,  
Bangladesh
To  the  Editor:  Guillain-Barré 
syndrome (GBS) is an acute periph-
eral neuropathy triggered by a preced-
ing  infectious  illness.  Gastroenteritis 
caused  by  Campylobacter  jejuni  is 
the most frequently reported anteced-
ent event (1). In Japan, South Africa, 
China,  and  Mexico,  Campylobacter 
strains with certain Penner heat-stable 
(HS) serotypes, including HS:19 and 
HS:41,  are  overrepresented  among 
isolates  from  GBS  case-patients, 
compared with isolates from enteritis 
case-patients (2,3). Several studies in-
dicate that C. jejuni HS:19 and HS:41 
have a clonal population structure and 
suggest  that  these  serotypes  might 
have unique virulence properties that 
are intricately linked to development 
of GBS (4). However, data from the 
United Kingdom and the Netherlands 
suggest  that  such  virulence  proper-
ties may not be restricted to specific 
HS serotypes because many other se-
rotypes can be cultured from patients 
with GBS (5). We report a non-HS:19 
and non-HS:41 C. jejuni serotype and 
sequence  type  (ST)–3219  that  are 
overrepresented among isolates from 
GBS patients in Bangladesh.
We  conducted  a  prospective 
case-control study of the serotype and 
genotype of C. jejuni associated with 
GBS  in  Bangladesh.  Case-patients 
were 97 persons with GBS admitted 
to  Dhaka  Medical  College  Hospital, 
Bangabandhu Sheikh Mujib Medical 
University,  and  Dhaka  Central  Hos-
pital  during  July  2006–June  2007. 
All  fulfilled  the  diagnostic  criteria 
for GBS of the National Institute of 
Neurological Disorders and Stroke of 
the US National Institutes of Health 
(Bethesda, MD, USA) (6). The control 
group comprised 97 patients with oth-
er neurologic diseases, matched with LETTERS
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case-patients by sex, age, and date of 
admission  to  the  hospital. A  second 
control  group  comprised  97  healthy 
family members of case-patients. Up 
to 3 stool samples were cultured from 
each case-patient and control.
Campylobacter strains were pre-
sumptively identified with Gram stain, 
oxidase,  and  hippurate  hydrolysis 
tests and confirmed with a C. jejuni 
species-specific PCR. Serotyping was 
performed at the National Laboratory 
for Enteric Pathogens, Canadian Sci-
ence  Centre  for  Human  and Animal 
Health, Winnipeg, Manitoba, Canada. 
All  strains  were  serotyped  accord-
ing to the HS serotyping schemes of 
Penner  et  al.  (7).  To  determine  the 
class  of  lipooligosaccharides  (LOS) 
locus in each of the C. jejuni strains, 
genomic  DNA  was  isolated  by  us-
ing the DNeasy tissue kit (QIAGEN, 
Venlo, the Netherlands). PCR analysis 
was performed with primer sets spe-
cific for classes A, B, C, D, and E (8).
We isolated C. jejuni from fecal 
samples of 10 case-patients. Campy-
lobacter strains were not isolated from 
the  control  groups  (p<0.001).  Sero-
typing of the 10 GBS-related strains 
showed 4 different HS serotypes. C. 
jejuni  HS:23  was  found  in  5  (50%) 
strains; HS:19, in 2 (20%); HS:55 and 
HS:21, in 1 strain each. One strain was 
untypeable according to the HS typing 
scheme. In a collection of clinical C. 
jejuni isolated during the same period 
from  patients  with  enteritis,  HS:23 
was encountered in 9 (28%) of 32 pa-
tients. Serotypes previously associat-
ed with GBS were HS:1, HS:2, HS:4, 
HS:4/50,  HS:5,  HS:10,  HS:13/65, 
HS:16, HS:19, HS:23, HS:35, HS:37, 
HS:41, HS:44, and HS:64 (5,9).
Nine (90%) of the C. jejuni iso-
lates  from  the  case-patients  had  the 
class A  or  class  B  LOS,  which  are 
highly associated with the presence of 
ganglioside-mimicking  structures  in 
LOS (10). Godschalk et al. found that 
14 (82%) of 17 GBS-associated iso-
lates possessed a class A/B/C locus (8). 
Parker et al. (10) found that all GBS-
related strains and 64% of the other 
clinical and environmental isolates be-
longed to LOS class A/B/C loci. The 
expression of ganglioside-mimicking 
structures in Campylobacter, LOS is 
considered essential for the induction 
of  autoantibodies  that  lead  to  GBS. 
Godschalk et al. (8) demonstrated that 
specific  genes  involved  in  C.  jejuni 
LOS biosynthesis are crucial for the 
induction of antiganglioside antibod-
ies that lead to GBS.
We  performed  multilocus  se-
quence typing to examine the overall 
genomic variation among 10 GBS-re-
lated C. jejuni strains. We identified 6 
different STs among the GBS-related 
C. jejuni strains (Table). However, ST-
3219 has a new combination of alleles 
and was identified in 4 strains. Con-
cordantly,  the  analysis  demonstrated 
that  C.  jejuni  isolates  with  serotype 
HS:23 were all ST-3219. Of particu-
lar interest, ST-985 (BD-67) shared 5 
alleles (aspA, uncA, glnA, glyA, pgm) 
with ST-3219 (Table).
Our findings of a C. jejuni HS:23 
serotype  and  ST-3219  that  is  highly 
prevalent among GBS-related C. jejuni 
strains from Bangladesh are consistent 
with previous observations that specific 
LOS types and serotypes are overrep-
resented among GBS-related C. jejuni 
strains. These observations support the 
hypothesis that, although a great vari-
ety of C. jejuni serotypes can be iso-
lated from GBS patients in some geo-
graphic areas, specific clonal serotypes 
and multilocus types are prevalent in 
GBS patients in other places. The as-
sociation of GBS with C. jejuni LOS 
class A/B/C is the only consistent find-
ing when universal collections of GBS-
associated strains are considered.
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Table.	Serotyping	and	multilocus	sequence	typing	analysis	of	Campylobacter jejuni	strains	associated	with	Guillain-Barré	syndrome,	
Bangladesh*
Allele,	no.	
Strain Year Disease
LOS
class
Penner
type(s)† ST aspA glnA gltA glyA pgm tkt uncA
BD-07 2006 GBS A HS:19 22 1 3 6 4 3 3 3
BD-10 2006 GBS/MFS B HS:23 3219 10 27 33 19 10 5 7
BD-22 2006 GBS B HS:23 3219 10 27 33 19 10 5 7
BD-27 2006 GBS A UT 587 1 2 42 4 90 25 8
BD-34 2006 GBS B HS:23 3219 10 27 33 19 10 5 7
BD-39 2006 GBS A HS:19 660 1 3 6 4 54 91 3
BD-67 2007 GBS/MFS B HS:23 985 10 27 89 19 10 132 7
BD-74 2007 GBS/MFS B HS:23 3219 10 27 33 19 10 5 7
BD-75 2007 GBS A HS:55 587 1 2 42 4 90 25 8
BD-94 2007 GBS E HS:21 2109 4 7 10 4 10 7 1
*LOS,	lipooligosaccharides;	ST,	sequence	type;	GBS,	Guillain-Barré	syndrome;	HS,	heat	stable;	MFS,	Miller-Fisher	syndrome;	UT,	untypeable.	
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Enzootic  
Sparganosis in 
Guangdong,  
People’s Republic 
of China
To the Editor: Sparganosis is a 
worldwide  parasitic  zoonosis  caused 
by  infection  with  spargana,  the  ple-
rocercoid larvae of various diphyllo-
bothroid tapeworms belonging to the 
genus Spirometra (1–3). Sparganosis 
poses a serious threat to human health; 
the spargana invade mainly the brain, 
eye,  abdominal  cavity,  spinal  cord, 
and subcutaneous tissues; can damage 
local tissues; and can cause blindness, 
paralysis, and even death (4,5).
In the People’s Republic of China, 
sparganosis has emerged as an impor-
tant foodborne parasitic disease, with 
≈1,000  human  cases  reported  in  22 
provinces during 1927–2007. Guang-
dong Province has the most cases (6). 
Persons  in  Guangdong  Province  eat 
frog  meat  and  place  frog  poultices 
made  from  raw  frog  meat  on  open 
wounds and lesions, which facilitates 
human infection with spargana. To as-
sess the risk for human infection with 
sparganosis  in  this  province  and  to 
strengthen public food safety aware-
ness, we conducted a comprehensive 
investigation of spargana infection in 
frogs, the second intermediate host of 
Spirometra.
By  necropsy  we  examined  for 
spargana  544  frogs  (446  Rana  ni-
gromaculata and 98 R. tigrina) from 
Yunfu,  Maoming,  and  Zhanjiang  in 
western Guangdong Province during 
October  2007–October  2008  (7).  Of 
these 544 frogs, 455 were wild, and 
89 were aquacultured. Spargana were 
found in 27.3% (124/455) of examined 
wild frogs; of these, 30.0% (107/357) 
were  R.  nigromaculata,  significantly 
more (p<0.05) than the 17.3% (17/98) 
that were R. tigrina. This finding sug-
gests  that  R.  nigromaculata  is  the 
main intermediate host of Spirometra 
in western Guangdong Province.
We found 719 spargana in infect-
ed wild frogs. The number of worms 
per  frog  ranged  from  1  to  41,  with 
an average of 5.8 worms per infected 
frog. No spargana were found in 89 
aquacultured R. nigromaculata frogs.
The examined wild frogs looked 
normal and healthy and had no obvi-
ous symptoms. During necropsy, we 
detected local edema, muscle bleeding, 
and fragile tissues in the tissues invad-
ed by spargana. We also found cysts in 
some tissues that contained 1 or a few 
worms. Spargana dissected from host 
tissue were flat, white worms, which 
continuously crept in the normal sa-
line. These worms ranged from 2 mm 
to 115 mm long and from 1 mm to 2 
mm wide.
Frogs are the second intermedi-
ate  hosts  of  Spirometra  spp.;  pigs, 
mice,  and  humans  become  infect-
ed  as  paratenic  hosts  by  ingesting 
Spirometra larvae in cyclops or frogs 
(8,9). Because persons in Guangdong 